October 17, 2024
11 min listen
Save
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of October 14, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more.
Read the full coverage here:
FDA approves Rybrevant for advanced lung cancer
Lung cancer screening orders in eligible patients higher with digital health program
FDA approves Opdivo regimen for resectable NSCLC
Study quantifies survival benefit of immunotherapy in metastatic NSCLC
FDA expands osimertinib approval for advanced non-small cell lung cancer
References:
Ward Y, et al. Cancer. 2024;doi:10.1002/cncr.35476.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
